FREMONT, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor ® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc. ...
The new Cytek Cloud digital ecosystem combines all of Cytek’s spectral panel design tools in one place and allows users to prepare experiments remotely prior to accessing the instrument. The benefit ...
FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions ...
Cytek Biosciences, Inc. announced that it will report its financial results for the fourth quarter and full year 2024 on February 27, 2025, after market close. A conference call to discuss these ...
Cytek Biosciences, Inc. announced that it will release its second quarter 2025 financial results on August 6, 2025, after market close. The company will host a conference call and webcast at 1:30 p.m.
Interested parties may access live and archived webcasts of the presentations for the Stephens and Piper Sandler events referenced above on the “Investors” section of the company website at: investors ...
FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB) today announced that Chris Williams has been appointed chief operating officer for the company. In this ...
There are still growth drivers that may positively play out in future quarters, so I'm still optimistic about Cytek Biosciences. Cytek's FY2024 adjusted EBITDA surged 77% YoY, indicating robust ...
Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, ...
FREMONT, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that it has been named "Overall BioTech Company of the Year” in the fourth annual BioTech ...
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Strategy” Q3 2022 investor letter. A copy of the same can be downloaded here. The ...
FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the ...